AL
Alector
ALEC·NASDAQS San Francisco CAFounded 2013250 employees
Small CapbiotechPublicNeurology
Platform: Immuno-neuro
Market Cap
$0.5B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ALEC)
Loading ALEC stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Rimanesiran | ALE-1927 | Phase 1 | 1 | EZH2 | Pompe | ||
| Rimaglumide | ALE-8313 | Phase 2 | 1 | IL-13 | SCD |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)